Drug Approval | October 18, 2023
Glenmark receives ANDA approval for Apremilast Tablets
Glenmark's current portfolio consists of 188 products authorized for distribution in the US
Glenmark's current portfolio consists of 188 products authorized for distribution in the US
Tagrisso is projected to be a pivotal contributor to AstraZeneca’s portfolio
Appointment further strengthens company’s expertise in fastest-growing therapeutic area to meet patient need
Franson will help biopharma clients design a phased approach to inform and execute clinical development plans
Dr. Dietmar Berger, has agreed to take the leadership of the team ad interim
Dr. Jain is a biotechnology industry veteran with more than two decades of experience in pharmaceutical development across her time with ChemoCentryx, AbbVie, Abbott Laboratories, and G.D. Searle and Co
Allam was serving recently as the CEO at Public Investment Fund
Acquisition expands Merck’s growing hematology portfolio
The company shall be engaged in the business of manufacturing of pharmaceutical, bio-pharmaceutical and biological products of any kind
A special purpose vehicle (SPV) formed by O2 Energy SG Pte Ltd, for generation and supply of renewable power
Subscribe To Our Newsletter & Stay Updated
